FibroGen Inc (NASDAQ: FGEN): Analyst View Points To Future Growth

FibroGen Inc (FGEN) concluded trading on Thursday at a closing price of $2.38, with 4.05 million shares of worth about $9.63 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 73.72% during that period and on Thursday the price saw a gain of about […]

Why Should You Put FibroGen Inc (NASDAQ: FGEN) On Your Portfolio?

Insiders at the company have transacted a total of 88 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 25 of these insider trades were purchases, accounting for 758,136 shares. Insider sales of the common stock occurred on 63 occasions, with total insider shares sold totaling […]

FibroGen Inc (NASDAQ: FGEN) Seen Running Too Hot, Let’s Look At This More Closely

PRIMECAP Management Co. recently announced the acquisition of new stake in FibroGen Inc (NASDAQ:FGEN). The institutional investor has increased its shareholding in the Healthcare company by 7.66% to 14.72 million shares with purchase of 1.05 million shares. This fresh investment now brings its stake to 14.97% valued currently at $13.05 million. In addition, Armistice Capital […]

FibroGen Inc (NASDAQ: FGEN) Stock In Prove Me State

PRIMECAP Management Co. has recently announced that it has increased stake in FibroGen Inc (NASDAQ:FGEN) by 7.66%. After grabbing 14.72 million shares, the institutional investor is now in possession of 1.05 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.99% having worth around $7.97 million. Moreover, Armistice […]